{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:08:20Z","timestamp":1790179700044,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020908","name":"Pfizer SAS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020908","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neurol.2025.06.006","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T11:15:08Z","timestamp":1752750908000},"page":"652-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Migraine management in France: Practices of general practitioners and neurologists"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7541-6916","authenticated-orcid":false,"given":"C.","family":"Lucas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Raclot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gugenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7378-1034","authenticated-orcid":false,"given":"B.","family":"Braithwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ducros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2025.06.006_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2025.06.006_bib0175","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Stovner","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.06.006_bib0180","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neurol.2021.07.001","article-title":"Revised guidelines of the French Headache Society for the diagnosis and management of migraine in adults. Part 1: diagnosis and assessment","volume":"177","author":"Demarquay","year":"2021","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2025.06.006_bib0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s10194-019-0993-0","article-title":"A narrative review on the burden of migraine: when the burden is the impact on people's life","volume":"20","author":"Leonardi","year":"2019","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurol.2025.06.006_bib0190","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","article-title":"Diagnosis and management of migraine in ten steps","volume":"17","author":"Eigenbrodt","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2025.06.006_bib0195","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine: epidemiology, burden, and comorbidity","volume":"37","author":"Burch","year":"2019","journal-title":"Neurol Clin"},{"key":"10.1016\/j.neurol.2025.06.006_bib0200","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","article-title":"The cost of headache disorders in Europe: the Eurolight project","volume":"19","author":"Linde","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2025.06.006_bib0205","first-page":"115","article-title":"Socio-economic impact of severe migraine in France: study in patients with at least","volume":"25","author":"Leiba","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2025.06.006_bib0210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1468-2982.2007.01461.x","article-title":"MIDAS and HIT-6 French translation: reliability and correlation between tests","volume":"28","author":"Magnoux","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2025.06.006_bib0215","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jad.2012.10.029","article-title":"A psychometric evaluation of the French Canadian version of the Hospital Anxiety and Depression Scale in a large primary care population","volume":"147","author":"Roberge","year":"2013","journal-title":"J Affect Disord"},{"key":"10.1016\/j.neurol.2025.06.006_bib0220","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.lpmfor.2022.10.024","article-title":"Recommandations pour la prise en charge de la migraine chez l\u2019adulte\u00a0: diagnostic et \u00e9valuation","volume":"3","author":"Demarquay","year":"2022","journal-title":"Presse Med Formation"},{"key":"10.1016\/j.neurol.2025.06.006_bib0225","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.neurol.2021.07.006","article-title":"Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: pharmacological treatment","volume":"177","author":"Ducros","year":"2021","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2025.06.006_bib0230","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability","volume":"79","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2025.06.006_bib0235","doi-asserted-by":"crossref","first-page":"e209175","DOI":"10.1212\/WNL.0000000000209175","article-title":"Neurodevelopmental and functional outcomes following in utero exposure to antiseizure medication","volume":"102","author":"Honybun","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.06.006_bib0240","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2309359","article-title":"Risk of autism after prenatal topiramate, valproate, or lamotrigine exposure","volume":"390","author":"Hern\u00e1ndez-D\u00edaz","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2025.06.006_bib0245","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1526-4610.2006.00430.x","article-title":"Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French Nationwide Population-Based Survey","volume":"46","author":"Lucas","year":"2004","journal-title":"Headache"},{"key":"10.1016\/j.neurol.2025.06.006_bib0250","unstructured":"La Voix des Migraineux, MoiPatient, CEKMA. \u00c9valuation de l\u2019exp\u00e9rience et du parcours de soin des patients.e.s migraineux n.d."},{"key":"10.1016\/j.neurol.2025.06.006_bib0255","doi-asserted-by":"crossref","DOI":"10.1177\/03331024231180611","article-title":"Chronic migraine epidemiology and outcomes\u00a0\u2013\u00a0International (CaMEO-I) Study: methods and multi-country baseline findings for diagnosis rates and care","volume":"43","author":"Adams","year":"2023","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2025.06.006_bib0260","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/head.14721","article-title":"Characterizing gaps in the preventive pharmacologic treatment of migraine: multi-country results from the CaMEO-I study","volume":"64","author":"Buse","year":"2024","journal-title":"Headache"},{"key":"10.1016\/j.neurol.2025.06.006_bib0265","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.neurol.2024.02.057","article-title":"Pratiques de prise en charge m\u00e9dicamenteuse des migraines et perception des nouveaux traitements par des m\u00e9decins neurologues","volume":"180","author":"Ducros","year":"2024","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2025.06.006_bib0270","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.neurol.2024.02.058","article-title":"Pratiques de prise en charge m\u00e9dicamenteuse des migraines par des m\u00e9decins g\u00e9n\u00e9ralistes","volume":"180","author":"Lucas","year":"2024","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2025.06.006_bib0275","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-2982.2005.01094.x","article-title":"Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study","volume":"26","author":"Damico","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2025.06.006_bib0280","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/13696998.2021.1953301","article-title":"Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened\/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain","volume":"24","author":"Vo","year":"2021","journal-title":"J Med Econ"},{"key":"10.1016\/j.neurol.2025.06.006_bib0285","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10194-011-0320-x","article-title":"Recommendations for headache service organisation and delivery in Europe","volume":"12","author":"Steiner","year":"2011","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurol.2025.06.006_bib0290","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/head.14395","article-title":"The teaching of headache medicine in France: a questionnaire-based study","volume":"62","author":"Beltramone","year":"2022","journal-title":"Headache"},{"key":"10.1016\/j.neurol.2025.06.006_bib0295","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.nrl.2021.10.012","article-title":"Characterisation of the management of patients with migraine in the primary care setting in Spain. Analysis of the results of the European My-LIFE anamnesis project","volume":"38","author":"D\u00edaz-Insa","year":"2023","journal-title":"Neurologia"},{"key":"10.1016\/j.neurol.2025.06.006_bib0300","unstructured":"DREES. mo 2024."},{"key":"10.1016\/j.neurol.2025.06.006_bib0305","first-page":"123","article-title":"Anti-calcitonin gene-related peptide (CGRP) therapies for migraine","volume":"73","author":"Moisset","year":"2023","journal-title":"Rev Prat"},{"key":"10.1016\/j.neurol.2025.06.006_bib0310","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/head.13074","article-title":"Insights into the functional anatomy behind the PREEMPT injection paradigm: guidance on achieving optimal outcomes","volume":"57","author":"Blumenfeld","year":"2017","journal-title":"Headache"},{"key":"10.1016\/j.neurol.2025.06.006_bib0315","unstructured":"Base de donn\u00e9es publique des m\u00e9dicaments. R\u00e9sum\u00e9 des caract\u00e9ristiques du produit\u00a0\u2013\u00a0BOTOX 200 UNIT\u00c9S ALLERGAN, poudre pour solution injectable 2024."},{"key":"10.1016\/j.neurol.2025.06.006_bib0320","unstructured":"Haute Autorit\u00e9 de sant\u00e9. BOTOX 50-100-200 UNIT\u00c9S ALLERGAN (toxine botulinique type A)\u00a0\u2013\u00a0Migraine chronique. Haute Autorit\u00e9 de sant\u00e9 n.d."},{"key":"10.1016\/j.neurol.2025.06.006_bib0325","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/nyas.12488","article-title":"Development of onabotulinumtoxinA for chronic migraine","volume":"1329","author":"Whitcup","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2025.06.006_bib0330","unstructured":"L\u00e9gifrance. Article R.\u00a01121-1\u00a0\u2013\u00a0Code de la sant\u00e9 publique 2021."}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725005466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725005466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T12:58:24Z","timestamp":1755953904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378725005466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0035378725005466"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.06.006","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Migraine management in France: Practices of general practitioners and neurologists","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}